PTEN is a negative regulator of Notch1 pathway, and disturbances in its activity (due to mutation or deletion) may be associated with unfavorable long-term outcomes in some cases of T-ALL (45, 46). Here, NOTCH1 is linked to acute lymphoblastic leukemia.